Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.

[1]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  W. Rutala,et al.  Healthcare Outbreaks Associated With a Water Reservoir and Infection Prevention Strategies. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Sobel,et al.  Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Donna M Wolk,et al.  T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. , 2016, Future microbiology.

[5]  O. Mccotter,et al.  Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012-2014. , 2015, MMWR. Morbidity and mortality weekly report.

[6]  Jinkyeong Park,et al.  Efficacy of chlorhexidine bathing for reducing healthcare associated bloodstream infections: a meta-analysis , 2015, Annals of Intensive Care.

[7]  J. Vincent,et al.  A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  W. Rutala,et al.  Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Marisa H Miceli,et al.  Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. Garey,et al.  T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Lorraine H. Linford,et al.  Impact of universal disinfectant cap implementation on central line-associated bloodstream infections. , 2014, American journal of infection control.

[12]  J. Stern,et al.  A Successful Approach to Reducing Bloodstream Infections Based on a Disinfection Device for Intravenous Needleless Connector Hubs , 2014, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[13]  S. Balajee,et al.  Mucormycosis Outbreak Associated With Hospital Linens , 2014, The Pediatric infectious disease journal.

[14]  A. Westfall,et al.  MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  T. Boekhout,et al.  Bloodstream infections by Malassezia and Candida species in critical care patients. , 2014, Medical mycology.

[16]  N. Yapar.  Epidemiology and risk factors for invasive candidiasis , 2014, Therapeutics and clinical risk management.

[17]  G. Alangaden,et al.  Mucormycosis in a Renal Transplant Recipient: Case Report and Comprehensive Review of Literature , 2014, International journal of nephrology.

[18]  J. Vazquez,et al.  Invasive fungal infections in transplant recipients , 2013, Therapeutic advances in infectious disease.

[19]  C. Tseng,et al.  Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-Analysis , 2013, PloS one.

[20]  E. Wong,et al.  Effect of daily chlorhexidine bathing on hospital-acquired infection. , 2013, The New England journal of medicine.

[21]  D. Horn,et al.  Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. , 2012, Diagnostic microbiology and infectious disease.

[22]  S. Magill,et al.  Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Claudio Viscoli,et al.  Occurrence, presentation and treatment of candidemia , 2012, Expert review of clinical immunology.

[24]  D. Horn,et al.  The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. , 2012, Diagnostic microbiology and infectious disease.

[25]  D. McKenna,et al.  Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. , 2012, The American journal of medicine.

[26]  C. Clancy,et al.  Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Han,et al.  Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia , 2012, Antimicrobial Agents and Chemotherapy.

[28]  P. Vanhems,et al.  Aspergillosis: nosocomial or community-acquired? , 2011, Medical mycology.

[29]  J. Sobel,et al.  Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit , 2011, Mycoses.

[30]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.

[31]  A. Rodloff,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion , 2010, Journal of Clinical Microbiology.

[32]  R. Weber,et al.  Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[33]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[34]  Nina Singh,et al.  Invasive Aspergillosis in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  W. Meyer,et al.  Molecular Epidemiology of Invasive Aspergillosis: Lessons Learned from an Outbreak Investigation in an Australian Hematology Unit , 2009, Infection Control & Hospital Epidemiology.

[36]  Russell E. Lewis,et al.  Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007) , 2009, Cancer.

[37]  Hermann Einsele,et al.  Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.

[38]  H. Yazaki,et al.  Outbreak of Pneumocystis jiroveci Pneumonia in Renal Transplant Recipients: P. jiroveci Is Contagious to the Susceptible Host , 2009, Transplantation.

[39]  V. Cheng,et al.  Outbreak of Intestinal Infection Due to Rhizopus microsporus , 2009, Journal of Clinical Microbiology.

[40]  M. Arduino,et al.  Contaminated Product Water as the Source of Phialemonium curvatum Bloodstream Infection among Patients Undergoing Hemodialysis , 2009, Infection Control & Hospital Epidemiology.

[41]  P. Hsueh,et al.  Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  E. Anaissie,et al.  Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  E. Manavathu,et al.  Aspergillus flavus: an emerging non‐fumigatus Aspergillus species of significance , 2009, Mycoses.

[44]  L. Romani,et al.  Invasive aspergillosis in chronic granulomatous disease. , 2009, Medical mycology.

[45]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  E. Anaissie,et al.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  K. Ho,et al.  Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature , 2009, Scandinavian journal of infectious diseases.

[48]  A. Antoniadou.  Outbreaks of zygomycosis in hospitals. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[49]  J. Guarro,et al.  Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? , 2008, Journal of Clinical Microbiology.

[50]  W. Popp,et al.  Environmental sampling of particulate matter and fungal spores during demolition of a building on a hospital area. , 2008, The Journal of hospital infection.

[51]  E. Bouza,et al.  Epidemiology of candidemia in intensive care units. , 2008, International journal of antimicrobial agents.

[52]  A. Hidrón,et al.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.

[53]  A. Gácser,et al.  Candida parapsilosis, an Emerging Fungal Pathogen , 2008, Clinical Microbiology Reviews.

[54]  S. Saint,et al.  Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.

[55]  K. Machin,et al.  Investigation and management of an outbreak of mucormycosis in a paediatric oncology unit. , 2008, The Journal of hospital infection.

[56]  M. Kollef,et al.  Secular Trends in Candidemia-Related Hospitalization in the United States, 2000–2005 , 2008, Infection Control & Hospital Epidemiology.

[57]  G. Slotman,et al.  Empirical Fluconazole versus Placebo for Intensive Care Unit Patients , 2008, Annals of Internal Medicine.

[58]  Jianping Xu,et al.  Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  D. Marriott,et al.  Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. , 2008, Critical care medicine.

[60]  D. Kontoyiannis,et al.  The changing epidemiology of invasive candidiasis , 2008, Cancer.

[61]  K. L. Mathews,et al.  Effect of Building Construction on Aspergillus Concentrations in a Hospital , 2008, Infection Control & Hospital Epidemiology.

[62]  W. Hop,et al.  Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  Raoul Herbrecht,et al.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  Thomas R Rogers,et al.  Treatment of zygomycosis: current and new options. , 2008, The Journal of antimicrobial chemotherapy.

[65]  R. Barton,et al.  Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005 , 2007, Journal of Clinical Microbiology.

[66]  F. Dalle,et al.  Prospective survey of indoor fungal contamination in hospital during a period of building construction. , 2007, The Journal of hospital infection.

[67]  K. Marr,et al.  Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients , 2007, British journal of haematology.

[68]  William E Trick,et al.  Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. , 2007, Archives of internal medicine.

[69]  D. Stevens,et al.  Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies , 2007, Mycopathologia.

[70]  K. Laupland,et al.  Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. , 2007, The Journal of antimicrobial chemotherapy.

[71]  W. Meersseman,et al.  Invasive aspergillosis in the ICU: an emerging disease , 2007, Intensive Care Medicine.

[72]  E. van Wijngaerden,et al.  Invasive aspergillosis in the intensive care unit. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  V. Anttila,et al.  The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration , 2007, Bone Marrow Transplantation.

[74]  T. Wong,et al.  Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore. , 2007, Archives of ophthalmology.

[75]  H. V. van Houwelingen,et al.  An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  W. Hughes.  Transmission of Pneumocystis species among renal transplant recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  J. Guinea,et al.  Impact of Zygomycosis on Microbiology Workload: a Survey Study in Spain , 2007, Journal of Clinical Microbiology.

[78]  P. Smith,et al.  Excess Costs of Hospital Care Associated With Neonatal Candidemia , 2007, The Pediatric infectious disease journal.

[79]  B. Alexander,et al.  Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[80]  M. Boeckh,et al.  Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  F. Dalle,et al.  Reduced fungal contamination of the indoor environment with the Plasmair system (Airinspace). , 2007, Journal of Hospital Infection.

[82]  J. Lipton,et al.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. , 2007, The New England journal of medicine.

[83]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[84]  J. Siegel,et al.  HEALTH CARE INFECTION CONTROL PRACTICES ADVISORY COMMITTEE. 2007 GUIDELINE FOR ISOLATION PRECAUTIONS: PREVENTING TRANSMISSION OF INFECTIOUS AGENTS IN HEALTH CARE SETTINGS , 2007 .

[85]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[86]  E. Freireich,et al.  Influence of high-efficiency particulate air filtration on mortality and fungal infection: a rebuttal. , 2006, The Journal of infectious diseases.

[87]  B. Spellberg,et al.  Deferiprone iron chelation as a novel therapy for experimental mucormycosis. , 2006, The Journal of antimicrobial chemotherapy.

[88]  M. Arduino,et al.  Outbreak of cutaneous Rhizopus arrhizus infection associated with karaya ostomy bags. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[89]  E. Leray,et al.  Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[90]  K. Wannemuehler,et al.  Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. , 2006, JAMA.

[91]  A. Webster,et al.  Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[92]  C. Claussen,et al.  Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. , 2006, AJR. American journal of roentgenology.

[93]  P. Gastmeier,et al.  Nosocomial aspergillosis in outbreak settings. , 2006, The Journal of hospital infection.

[94]  M. Falagas,et al.  Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[95]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[96]  M. Cuenca‐Estrella,et al.  Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003 , 2006, Journal of Clinical Microbiology.

[97]  Kieren A. Marr,et al.  Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata , 2006, Journal of Clinical Microbiology.

[98]  D. Kontoyiannis,et al.  Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[99]  J. Garnacho-Montero,et al.  A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.

[100]  G. Klintmalm,et al.  Combination of Voriconazole and Caspofungin as Primary Therapy for Invasive Aspergillosis in Solid Organ Transplant Recipients: A Prospective, Multicenter, Observational Study , 2006, Transplantation.

[101]  S. Holland,et al.  Immunotherapy for fungal infections. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  M. Bassetti,et al.  Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.

[103]  R. Porcher,et al.  Occurrence and Kinetics of False-Positive Aspergillus Galactomannan Test Results following Treatment with β-Lactam Antibiotics in Patients with Hematological Disorders , 2006, Journal of Clinical Microbiology.

[104]  M. Choti,et al.  Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy , 2006, Journal of Clinical Microbiology.

[105]  D. Maki,et al.  Disinfection of Needleless Catheter Connectors and Access Ports With Alcohol May Not Prevent Microbial Entry: The Promise of a Novel Antiseptic-Barrier Cap , 2006, Infection Control & Hospital Epidemiology.

[106]  A. Baruch,et al.  Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin , 2005, Journal of clinical pharmacology.

[107]  S. Fridkin.  The changing face of fungal infections in health care settings. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[108]  U. Nawrot,et al.  Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases , 2005, Mycoses.

[109]  Michael Y. Lin,et al.  Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study , 2005, Antimicrobial Agents and Chemotherapy.

[110]  J. Berlin,et al.  The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[111]  C. Viscoli,et al.  Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial , 2005, The Lancet.

[112]  L. Leibovici,et al.  Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. , 2005, The Journal of hospital infection.

[113]  C. Kauffman,et al.  Candida glabrata fungemia: experience in a tertiary care center. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[114]  P. Pitisuttithum,et al.  Activity of posaconazole in the treatment of central nervous system fungal infections. , 2005, The Journal of antimicrobial chemotherapy.

[115]  J. Perfect,et al.  Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole. , 2005, Transplantation.

[116]  P. de Mol,et al.  An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit. , 2005, The Journal of hospital infection.

[117]  K. J. Lee,et al.  CT halo sign: the spectrum of pulmonary diseases. , 2005, The British journal of radiology.

[118]  C. Lengerke,et al.  Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? , 2005, European journal of radiology.

[119]  D. Kontoyiannis,et al.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[120]  Victoria J. Fraser,et al.  Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.

[121]  C. Lengerke,et al.  Invasive pulmonary aspergillosis: frequency and meaning of the "hypodense sign" on unenhanced CT. , 2005, The British journal of radiology.

[122]  F. Gavini,et al.  Bifidobacterial Lipoglycan as a New Cause for False-Positive Platelia Aspergillus Enzyme-Linked Immunosorbent Assay Reactivity , 2005, Journal of Clinical Microbiology.

[123]  M. Arduino,et al.  Saline-filled breast implant contamination with Curvularia species among women who underwent cosmetic breast augmentation. , 2005, The Journal of infectious diseases.

[124]  Brad Spellberg,et al.  Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management , 2005, Clinical Microbiology Reviews.

[125]  S. Teutsch,et al.  Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance , 2005, Infection Control & Hospital Epidemiology.

[126]  S. Fridkin,et al.  Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 , 2005, Journal of Clinical Microbiology.

[127]  L. Pagano,et al.  Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature , 2005, Journal of Clinical Microbiology.

[128]  N. Chao,et al.  Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant , 2005, Antimicrobial Agents and Chemotherapy.

[129]  G. Rahav,et al.  An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[130]  J. Garnacho-Montero,et al.  Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome , 2005, Critical care.

[131]  B. Spellberg,et al.  Caspofungin Inhibits Rhizopus oryzae 1,3-β-d-Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis , 2005, Antimicrobial Agents and Chemotherapy.

[132]  M. Bértoli,et al.  High frequency of Candida parapsilosis on the hands of healthy hosts. , 2005, The Journal of hospital infection.

[133]  S. Pitlik,et al.  Unexpected candidemia complicating ureteroscopy and urinary stenting , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[134]  E. Bouza,et al.  Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[135]  Y. Shan,et al.  Early Presumptive Therapy with Fluconazole for Occult Candida Infection after Gastrointestinal Surgery , 2005, World Journal of Surgery.

[136]  D. Denning,et al.  Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[137]  J. Lipton,et al.  Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[138]  J. Robinson,et al.  Genetic Diversity of Human Pathogenic Members of the Fusarium oxysporum Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment Length Polymorphism Analyses: Evidence for the Recent Dispersion of a Geographically Widespread Clonal Lineage and Nosocomial Origin , 2004, Journal of Clinical Microbiology.

[139]  R. Prasad,et al.  Epidemiology and molecular typing of Candida isolates from burn patients , 2004, Mycopathologia.

[140]  U. Theuretzbacher.  Pharmacokinetics/pharmacodynamics of echinocandins , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[141]  Peter J Pronovost,et al.  Eliminating catheter-related bloodstream infections in the intensive care unit* , 2004, Critical care medicine.

[142]  Ray Y. Hachem,et al.  Aspergillus terreus , 2004, Cancer.

[143]  S. Fridkin,et al.  Epidemiologic and Molecular Characterization of an Outbreak of Candida parapsilosis Bloodstream Infections in a Community Hospital , 2004, Journal of Clinical Microbiology.

[144]  M. Pfaller,et al.  Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus , 2004, Journal of Clinical Microbiology.

[145]  P. Vanhems,et al.  Molecular Evidence of Interhuman Transmission of Pneumocystis Pneumonia among Renal Transplant Recipients Hospitalized with HIV-Infected Patients , 2004, Emerging infectious diseases.

[146]  D. Denning.  Aspergillosis in "nonimmunocompromised" critically ill patients. , 2004, American journal of respiratory and critical care medicine.

[147]  L. Bartelt,et al.  Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[148]  T. Walsh,et al.  Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. , 2004, The Pediatric infectious disease journal.

[149]  D. Kontoyiannis,et al.  Trichosporonosis in a tertiary care cancer center: Risk factors, changing spectrum and determinants of outcome , 2004, Scandinavian journal of infectious diseases.

[150]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[151]  R. Summerbell,et al.  Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[152]  G. Morace,et al.  In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[153]  J. Perfect,et al.  Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[154]  E. Thiel,et al.  Improved Outcome of Zygomycosis in Patients with Hematological Diseases? , 2004, Leukemia & lymphoma.

[155]  N. Nolard,et al.  Environmental investigations and molecular typing of Aspergillus flavus during an outbreak of postoperative infections. , 2004, The Journal of hospital infection.

[156]  C. Wallis,et al.  Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum , 2004, The British journal of dermatology.

[157]  M. Ghannoum,et al.  Candida parapsilosis Characterization in an Outbreak Setting , 2004, Emerging infectious diseases.

[158]  A. Tortorano,et al.  Candidosis in the intensive care unit: a 20-year survey. , 2004, The Journal of hospital infection.

[159]  E. Anaissie,et al.  Fusarium infection in hematopoietic stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[160]  A. Tarkkanen,et al.  Fungal endophthalmitis caused by Paecilomyces variotii following cataract surgery: a presumed operating room air-conditioning system contamination. , 2004, Acta ophthalmologica Scandinavica.

[161]  F. Colardyn,et al.  Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. , 2004, The Journal of hospital infection.

[162]  Larry J. Anderson,et al.  Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, Respiratory care.

[163]  F. Marty,et al.  Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. , 2004, The New England journal of medicine.

[164]  D. Pittet,et al.  Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[165]  M. Ghannoum,et al.  Candida biofilms: antifungal resistance and emerging therapeutic options. , 2004, Current opinion in investigational drugs.

[166]  J. Sobel,et al.  Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[167]  F. Derouin,et al.  Successful Treatment of Pulmonary Mucormycosis in an Allogenic Bone-marrow Transplant Recipient with Combined Medical and Surgical Therapy , 2004, Scandinavian journal of infectious diseases.

[168]  Acip.  Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .

[169]  J. Pemán,et al.  Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[170]  E. Mellado,et al.  Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients , 2004, Intensive Care Medicine.

[171]  A. Sulahian,et al.  False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. , 2003, The New England journal of medicine.

[172]  Jien-Wei Liu,et al.  Rhinocerebral mucormycosis in Taiwan. , 2003, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[173]  N. Katsilambros,et al.  Mucormycosis: Ten-Year Experience at a Tertiary-Care Center in Greece , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[174]  R. Luzzati,et al.  Nosocomial Cluster of Candida guillermondii Fungemia in Surgical Patients , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[175]  J. Quenot,et al.  Candidemia in critically ill patients: difference of outcome between medical and surgical patients , 2003, Intensive Care Medicine.

[176]  J. Thornby,et al.  Candidemia in a Tertiary Care Cancer Center: In Vitro Susceptibility and its Association with Outcome of Initial Antifungal Therapy , 2003, Medicine.

[177]  W. Powderly,et al.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[178]  R. Salomão,et al.  Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy. , 2003, Diagnostic microbiology and infectious disease.

[179]  R. Wenzel,et al.  Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities , 2003, The Pediatric infectious disease journal.

[180]  J. Perfect,et al.  Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[181]  E. Anaissie,et al.  Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection , 2003, Cancer.

[182]  G. Bernard,et al.  Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[183]  J. Miro,et al.  Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1). , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[184]  I. Gosbell,et al.  Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery , 2003, Mycoses.

[185]  J. Sobel,et al.  A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[186]  M. Territo,et al.  Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial , 2003, Annals of Internal Medicine.

[187]  R. Wenzel,et al.  Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[188]  M. Pfaller,et al.  Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001 , 2003, Journal of Clinical Microbiology.

[189]  T. Kazui,et al.  Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. , 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[190]  John H Rex,et al.  Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. , 2003, Blood.

[191]  M. Fariñas,et al.  Candidemia in a Tertiary Care Hospital: Epidemiology and Factors Influencing Mortality , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[192]  M. Manfait,et al.  Use of Fourier-Transform Infrared Spectroscopy for Typing of Candidaalbicans Strains Isolated in Intensive Care Units , 2003, Journal of Clinical Microbiology.

[193]  A. Schwarer,et al.  Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and Terbinafine , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[194]  P. Francioli,et al.  Risk for Pneumocystis carinii Transmission among Patients with Pneumonia: a Molecular Epidemiology Study , 2003, Emerging infectious diseases.

[195]  Nina Singh,et al.  Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[196]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[197]  P. Duvaldestin,et al.  Molecular diversity and routes of colonization of Candida albicans in a surgical intensive care unit, as studied using microsatellite markers. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[198]  F. Gritti,et al.  Invasive Aspergillosis in Italian AIDS Patients , 2002, Infection.

[199]  E. Anaissie,et al.  Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[200]  Kerrayem Alsuwaida.  Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[201]  J. Duchin,et al.  The role of person-to-person transmission in an epidemiologic study of Pneumocystis carinii pneumonia , 2002, AIDS.

[202]  D. Armstrong,et al.  Prospective epidemiologic analysis of triazole-resistant nosocomial Candida glabrata isolated from patients at a comprehensive cancer center. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[203]  R. Gaynes,et al.  Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[204]  J. Wingard,et al.  A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[205]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[206]  C. Maslo,et al.  Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. , 2002, The Journal of hospital infection.

[207]  E. Ghelardi,et al.  Horizontal Transmission of Candida parapsilosis Candidemia in a Neonatal Intensive Care Unit , 2002, Journal of Clinical Microbiology.

[208]  L. Ekelund,et al.  Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. , 2002, Acta radiologica.

[209]  B. D. de Pauw,et al.  Impaired gut function as risk factor for invasive candidiasis in neutropenic patients , 2002, British journal of haematology.

[210]  Y. Kanda,et al.  Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy‐based study involving 720 patients with haematological malignancy , 2002, British journal of haematology.

[211]  M. Pfaller,et al.  Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study , 2002, Journal of Clinical Microbiology.

[212]  Robert F Miller,et al.  Probable Mother-to-Infant Transmission of Pneumocystis carinii f. sp. hominis Infection , 2002, Journal of Clinical Microbiology.

[213]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[214]  E. Anaissie,et al.  Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[215]  M. Ghannoum,et al.  Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces , 2002, Infection and Immunity.

[216]  S. Joly,et al.  Carriage Frequency, Intensity of Carriage, and Strains of Oral Yeast Species Vary in the Progression to Oral Candidiasis in Human Immunodeficiency Virus-Positive Individuals , 2002, Journal of Clinical Microbiology.

[217]  H. Giamarellou.  Nosocomial cardiac infections. , 2002, The Journal of hospital infection.

[218]  H. Kantarjian,et al.  Masking of Neutropenic Patients on Transport From Hospital Rooms Is Associated With a Decrease in Nosocomial Aspergillosis During Construction , 2002, Infection Control & Hospital Epidemiology.

[219]  W. Hope,et al.  Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. , 2002, The Journal of hospital infection.

[220]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[221]  J. Wingard,et al.  Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital , 2002, Bone Marrow Transplantation.

[222]  J. Beney,et al.  The direct cost and incidence of systemic fungal infections. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[223]  E. Anaissie,et al.  Revisiting the source of candidemia: skin or gut? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[224]  L. Saiman,et al.  Risk factors for Candida species colonization of neonatal intensive care unit patients. , 2001, The Pediatric infectious disease journal.

[225]  D. Wolf,et al.  Multidrug-Resistant Trichosporon asahii Infection of Nongranulocytopenic Patients in Three Intensive Care Units , 2001, Journal of Clinical Microbiology.

[226]  S. Chanock,et al.  Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[227]  J. Thornby,et al.  Risk Factors for Candida tropicalis fungemia in patients with cancer. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[228]  R. Hajjeh,et al.  Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[229]  S. Singhal,et al.  Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome , 2001, Bone Marrow Transplantation.

[230]  E. Anaissie,et al.  Nosocomial aspergillosis is waterborne. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[231]  P. Vos,et al.  Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non–bone marrow transplant setting , 2001, Cancer.

[232]  G. Samonis,et al.  Effects of Cefepime and Meropenem on the Gastrointestinal Colonization ofSurgical Patients by Candida albicans , 2001, Chemotherapy.

[233]  L. Saiman,et al.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[234]  F. Derouin,et al.  Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. , 2001, The Journal of hospital infection.

[235]  J. Rodríguez-Tudela,et al.  Airborne outbreak of nosocomial Scedosporium prolificans infection , 2001, The Lancet.

[236]  C. Payá,et al.  Fusarium infection after solid-organ transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[237]  J. Rowe,et al.  Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters , 2001, American journal of hematology.

[238]  B. Petrini,et al.  Malassezia pachydermatis fungaemia in a neonatal intensive care unit , 2001, Acta paediatrica.

[239]  M. Libman,et al.  Prevalence and Antifungal Susceptibility of 442Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada , 2001, Journal of Clinical Microbiology.

[240]  G. Mcleod,et al.  Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[241]  H. Kantarjian,et al.  Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia , 2001, Leukemia & lymphoma.

[242]  R. Khatib,et al.  Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. , 2001, Scandinavian journal of infectious diseases.

[243]  Y. Tselentis,et al.  The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans. , 2001, Scandinavian journal of infectious diseases.

[244]  S. Fanello,et al.  Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person transmission. , 2001, The Journal of hospital infection.

[245]  A. Bernard,et al.  Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[246]  K. Marr.  The changing spectrum of candidemia in oncology patients: therapeutic implications , 2000, Current opinion in infectious diseases.

[247]  S. Saint,et al.  Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. , 2000, Diagnostic microbiology and infectious disease.

[248]  A. Fauser,et al.  Review of comparative studies between conventional and liposomal amphotericin B (Ambisome®) in neutropenic patients with fever of unknown origin and patients with systemic mycosis , 2000, Mycoses.

[249]  G. Bodey,et al.  Candida krusei fungemia. An escalating serious infection in immunocompromised patients. , 2000, Archives of internal medicine.

[250]  In vitro effects of interleukin-10, prednisolone, and GM-CSF on the non-specific immune function of human polymorphonuclear leucocytes and monocytes. , 2000, European journal of medical research.

[251]  M. Cawley,et al.  Trichosporon beigelii infection: experience in a regional burn center. , 2000, Burns : journal of the International Society for Burn Injuries.

[252]  S. Piscitelli,et al.  Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. , 2000, The Journal of infectious diseases.

[253]  H. Einsele,et al.  Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. , 2000, The Journal of infectious diseases.

[254]  D. Denning,et al.  Practice Guidelines for Diseases Caused by Aspergillus , 2000 .

[255]  Sergio L Vargas,et al.  Transmission of Pneumocystis carinii DNA from a Patient with P. carinii Pneumonia to Immunocompetent Contact Health Care Workers , 2000, Journal of Clinical Microbiology.

[256]  M. Richardson,et al.  Sampling of Aspergillus spores in air. , 2000, The Journal of hospital infection.

[257]  D. Denning,et al.  Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[258]  S. Bellino,et al.  Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[259]  T. C. White,et al.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. , 2000, The Journal of infectious diseases.

[260]  R. Busuttil,et al.  Prophylactic Fluconazole in Liver Transplant Recipients , 1999, Annals of Internal Medicine.

[261]  R. Pinner,et al.  The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[262]  J. Šufliarský,et al.  Nosocomial candidaemias due to species other than Candida albicans in cancer patients , 1999, Supportive Care in Cancer.

[263]  L. Saiman,et al.  Elucidating the Origins of Nosocomial Infections with Candida albicans by DNA Fingerprinting with the Complex Probe Ca3 , 1999, Journal of Clinical Microbiology.

[264]  L. Mele,et al.  Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes , 1999, European journal of haematology.

[265]  G. Verhoef,et al.  Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis , 1999, Bone Marrow Transplantation.

[266]  L. Saiman,et al.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[267]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[268]  S. Sanche,et al.  In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus, with a Head-to-Head Comparison to Voriconazole , 1999, Journal of Clinical Microbiology.

[269]  G. Fadda,et al.  Candidemia in HIV-Infected Subjects , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[270]  A. Borzotta,et al.  Candida infections in critically ill trauma patients: a retrospective case-control study. , 1999, Archives of surgery.

[271]  P. Francioli,et al.  Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. , 1999, Critical care medicine.

[272]  M. Arisawa,et al.  Epidemiology of Visceral Mycoses: Analysis of Data in Annual of the Pathological Autopsy Cases in Japan , 1999, Journal of Clinical Microbiology.

[273]  A. van Belkum,et al.  Density and Molecular Epidemiology ofAspergillus in Air and Relationship to Outbreaks ofAspergillus Infection , 1999, Journal of Clinical Microbiology.

[274]  J. Cornish,et al.  Infections in adults undergoing unrelated donor bone marrow transplantation , 1999, British journal of haematology.

[275]  A. Michalopoulos,et al.  Severe sepsis in cardiac surgical patients. , 2003, The European journal of surgery = Acta chirurgica.

[276]  R. Pinner,et al.  The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[277]  W. Jänisch,et al.  Vorkommen von Endomykosen im Obduktionsgut der Berliner Charité , 1998 .

[278]  D. Niederwieser,et al.  In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. , 1998, The Journal of antimicrobial chemotherapy.

[279]  C. Leutner,et al.  Changing role of invasive aspergillosis in AIDS--a case control study. , 1998, Journal of Infection.

[280]  R Sylvester,et al.  An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. , 1998, The Journal of infection.

[281]  P. Kvale,et al.  Risk Factors and Outcomes Associated With Identification of Aspergillus in Respiratory Specimens From Persons With HIV Disease , 1998 .

[282]  J. Rich,et al.  Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. , 1998, Chest.

[283]  E. Kossoff,et al.  Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. , 1998, The Pediatric infectious disease journal.

[284]  E. Anaissie,et al.  Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[285]  M. A. Martin,et al.  National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. , 1998, Diagnostic microbiology and infectious disease.

[286]  D. Geiger,et al.  Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. , 1998, Diagnostic microbiology and infectious disease.

[287]  D. Ashford,et al.  An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs. , 1998, The New England journal of medicine.

[288]  S. Špánik,et al.  Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. , 1998, The Journal of antimicrobial chemotherapy.

[289]  E. Anaissie,et al.  Predictors of adverse outcome in cancer patients with candidemia. , 1998, The American journal of medicine.

[290]  J. Sobel,et al.  Nosocomial Candida glabrata Colonization: an Epidemiologic Study , 1998, Journal of Clinical Microbiology.

[291]  M. Carrier,et al.  Epidemiological study of Candida spp. colonization in cardiovascular surgical patients , 1997, Mycoses.

[292]  J. Karlowsky,et al.  Candidemia in a Canadian tertiary care hospital from 1976 to 1996. , 1997, Diagnostic microbiology and infectious disease.

[293]  J. Martínez-Suárez,et al.  Use of Random Amplification of Polymorphic DNA (RAPD) and PCR-Fingerprinting for Genotyping a Scedosporium prolificans (inflatum) Outbreak in Four Leukemic Patients , 1997, Current Microbiology.

[294]  M. Antunes,et al.  Mediastinitis after aorto-coronary bypass surgery. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[295]  E. Anaissie,et al.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. , 1997, Blood.

[296]  M. Ghannoum,et al.  International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[297]  W. Leisenring,et al.  Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.

[298]  B. Crowley,et al.  Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation , 1997, Bone Marrow Transplantation.

[299]  S. Špánik,et al.  Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome. , 1997, Scandinavian journal of infectious diseases.

[300]  A. Sitges-Serra,et al.  Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy , 1997, Intensive Care Medicine.

[301]  P. Itin,et al.  Outbreak of Invasive Mycoses Caused by Paecilomyces lilacinus from a Contaminated Skin Lotion , 1996, Annals of Internal Medicine.

[302]  D. Dunn,et al.  Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. , 1996, Journal of the American College of Surgeons.

[303]  M. Hocking,et al.  Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors , 1996, The Lancet.

[304]  M. Pfaller.  Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[305]  E. Bryce,et al.  An outbreak of cutaneous aspergillosis in a tertiary-care hospital. , 1996 .

[306]  A. van Belkum,et al.  Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward , 1996, Journal of clinical microbiology.

[307]  G. Nimmo,et al.  Subcutaneous Zygomycosis Due To Saksenaea Vasiformis: Rapid isolate identification using a modified sporulation technique , 1996, Pathology.

[308]  J. Martínez-Suárez,et al.  Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients , 1995, Journal of clinical microbiology.

[309]  S. Werner,et al.  Nosocomial outbreak of Candida albicans sternal wound infections following cardiac surgery traced to a scrub nurse. , 1995, The Journal of infectious diseases.

[310]  J. Dupouy-Camet,et al.  Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit , 1995, Journal of clinical microbiology.

[311]  M. Levenstein,et al.  Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. , 1995, The Journal of infectious diseases.

[312]  M. Pfaller,et al.  Epidemiology of candidiasis. , 1995, The Journal of hospital infection.

[313]  W. Jarvis.  Epidemiology of nosocomial fungal infections, with emphasis on Candida species. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[314]  R. Auckenthaler,et al.  Candida Colonization and Subsequent Infections in Critically III Surgical Patients , 1994, Annals of surgery.

[315]  M. Levenstein,et al.  A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia , 1994 .

[316]  M. Schmidt,et al.  Glucocorticoid-induced alterations of monocyte defense mechanisms against Candida albicans. , 1994, Cellular immunology.

[317]  R. Rubin,et al.  Clinical aspects of fungal infection in organ transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[318]  J. Perfect,et al.  NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. , 1994, The American journal of medicine.

[319]  C. E. Davis,et al.  Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient , 1994, Journal of clinical microbiology.

[320]  V. Morrison,et al.  Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. , 1994, The American journal of medicine.

[321]  B. Doebbeling,et al.  Investigation of the sequence of colonization and candidemia in nonneutropenic patients , 1994, Journal of clinical microbiology.

[322]  J. Lowe,et al.  Pulmonary mucormycosis: results of medical and surgical therapy. , 1994, The Annals of thoracic surgery.

[323]  O. Zmora,et al.  Altered gut barrier function to Candida during parenteral nutrition. , 1994, Nutrition.

[324]  R. Ali,et al.  Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories , 1994, Journal of clinical microbiology.

[325]  R. Khatib,et al.  Candidemia: current epidemiologic characteristics and a long-term follow-up of the survivors. , 1994, Scandinavian journal of infectious diseases.

[326]  F. Bongard,et al.  Candida sepsis in surgical patients. , 1993, American journal of surgery.

[327]  D. Armstrong,et al.  Catheter-related Malassezia furfur fungemia in immunocompromised patients. , 1993, The American journal of medicine.

[328]  F. Mandelli,et al.  Fungemia in Patients with Leukemia , 1993, The American journal of the medical sciences.

[329]  A. Telenti,et al.  Candidemia from a urinary tract source: microbiological aspects and clinical significance. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[330]  H. Bingham,et al.  Natural history of bloodstream infections in a burn patient population: the importance of candidemia. , 1993, American journal of infection control.

[331]  J. Sobel,et al.  Nosocomial acquisition of Candida albicans: an epidemiologic study. , 1993, The Journal of infectious diseases.

[332]  Y. Schneider,et al.  Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. , 1993, The Journal of clinical investigation.

[333]  A. Tärnvik,et al.  A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[334]  V. Fraser,et al.  Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[335]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[336]  F. Meunier,et al.  Candidemia in immunocompromised patients. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[337]  T. Barlam,et al.  Invasive aspergillosis in patients with AIDS. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[338]  W. Martone,et al.  Predominant pathogens in hospital infections. , 1992, The Journal of antimicrobial chemotherapy.

[339]  P. Fenaux,et al.  Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. , 1991, The Journal of antimicrobial chemotherapy.

[340]  R. Wenzel,et al.  Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[341]  B. Fox,et al.  Heavy contamination of operating room air by Penicillium species: identification of the source and attempts at decontamination. , 1990, American journal of infection control.

[342]  B. Dupont.  Itraconazole therapy in aspergillosis: study in 49 patients. , 1990, Journal of the American Academy of Dermatology.

[343]  P. Francioli,et al.  CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS , 1989, The Lancet.

[344]  B. Strom,et al.  Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. , 1989, The American journal of medicine.

[345]  F. Mandelli,et al.  Candida colonization and systemic infection in neutropenic patients. A retrospective study , 1989, Cancer.

[346]  T. Rogers,et al.  Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. , 1989, The Journal of hospital infection.

[347]  H. Richet,et al.  Cluster of Malassezia furfur pulmonary infections in infants in a neonatal intensive-care unit , 1989, Journal of clinical microbiology.

[348]  R. Rubin,et al.  Invasive aspergillus infection: possible non-ward common source within the hospital environment. , 1989, The Journal of hospital infection.

[349]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[350]  A. Gratwohl,et al.  Bottled lemon juice--a cryptic source of invasive Candida infections in the immunocompromised host. , 1988, The Journal of infectious diseases.

[351]  C. Hill,et al.  Risk factors for candidemia in cancer patients: a case-control study , 1988, Journal of clinical microbiology.

[352]  B. Kramer,et al.  Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. , 1987, The American journal of medicine.

[353]  E. Anaissie,et al.  Pneumonia with cunninghamella species in patients with hematologic malignancies: A case report and review of the literature , 1986, Cancer.

[354]  V. Yu,et al.  Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. , 1986, The American journal of medicine.

[355]  R. Jones,et al.  Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. , 1986, The Journal of pediatrics.

[356]  D. Rotrosen,et al.  Adherence of Candida species to host tissues and plastic surfaces. , 1986, Reviews of infectious diseases.

[357]  A. Callow,et al.  Candida Infections in Surgical Patients , 1983, Annals of surgery.

[358]  W. Lee,et al.  Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis , 1982, Cancer.

[359]  M. Okada,et al.  Present state of fungal infections in autopsy cases in Japan. , 1980, American journal of clinical pathology.

[360]  J. Mead,et al.  Cutaneous Rhizopus infection. Occurrence as a postoperative complication associated with an elasticized adhesive dressing. , 1979, JAMA.

[361]  G. Keusch,et al.  Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. , 1978, The New England journal of medicine.

[362]  A. Bayer,et al.  Candida peritonitis. Report of 22 cases and review of the English literature. , 1976, The American journal of medicine.

[363]  K. Kwon-Chung,et al.  Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. , 1975, American journal of clinical pathology.

[364]  R. Hurley,et al.  The growth of Candida species in cultures of mouse peritoneal macrophages , 1969, The Journal of pathology.

[365]  M. Seelig.  The role of antibiotics in the pathogenesis of Candidainfections. , 1966, The American journal of medicine.

[366]  R. Persellin,et al.  Fungal endocarditis following cardiac surgery. , 1961, Annals of internal medicine.